The Most Practical and Exclusive Conference for Global Clinical Trials
SHANGHAI– International Multi-center Clinical Trials are considered a quick method for pharmaceutical companies to get their products into the global market. Currently, over 15,000 global clinical trials are being conducted in the larger Asia Pacific market, which includes a growing number of trials conducted in China. According to the SFDA, there is increasing popularity to use China as a location for clinical trials, and many more pharmaceutical companies are also choosing China as their global clinical trial center.
To provide an inside view into global clinical trials in China, Noppen, in co-organization with the Shanghai Clinical Research Centre (SCRC), brought the International Multi-center Clinical Trials conference to Shanghai on the 9-10 December 2010. As the 4th Annual Conference in Noppen's Clinical Trial Series and supported by the American General Business Association (AGBA), it was a platform to help over 70 industry leaders optimize global clinical processes while ensuring regulatory compliance. It provided knowledge of changing government regulations and helped build a clinical strategy to successfully introduce products quickly to the market.